Tubac, Danny H.

HRN: 05-33-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/14/2022
08/20/2022
IV
500mg
Q8
Ameobiasis
Waiting Final Action 
08/15/2022
CEFTRIAXONE 1G (VIAL)
08/15/2022
08/21/2022
IV
2g
OD
Acute Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: